Algert Global LLC Compugen LTD Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$0.66 - $2.32 $44,899 - $157,829	68,030 Added 135.41%	118,270 $78,000
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $16,171 - $34,299	-10,300 Reduced 17.01%	50,240 $93,000
Q1 2022 May 16, 2022	BUY	$2.76 - $4.64 $91,825 - $154,372	33,270 Added 122.0%	60,540 $195,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $111,534 - $195,253	27,270 New	27,270 $117,000
Q2 2021 Aug 13, 2021	SELL	$6.87 - $9.16 $221,214 - $294,952	-32,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$7.67 - $13.77 $246,974 - $443,394	32,200 New	32,200 $277,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.